Direxion Daily S&P Biotech Bull 3X ETF Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (30)

Latest Posts

About This Stock More About This Stock
A Biotech ETF For Aggressive, Risk-Tolerant Investors
Article By: Benzinga
Tuesday, June 8, 2021 2:11 PM EST
The Direxion Daily S&P Biotech Bull 3X Shares ETF (LABU) seeks the daily investment results, before fees and expenses, of 300% of the performance of the S&P Biotechnology Index for a single day.
In this article: LABU
Read
5 Best-Performing Leveraged ETFs Of Fourth Quarter
Article By: Sweta Killa
Wednesday, December 23, 2020 2:36 PM EST
Here are some leveraged ETFs that gained more than 85% over the past three months. These funds will continue to be investors’ darlings provided the sentiments remain bullish.
In this article: SOXL, TNA, DPST, LABU, HIBL Also: PFE, MRNA
Read
The Week Ahead Commentary
Video By: Robert Desmond
Sunday, June 7, 2020 8:15 PM EST
In all probability the dollar is going lower. Odds favor the bears. In the stock markets, this is not mom-and-pop buying we're seeing.
In this video: QQQ, SMH, TIP, TLT, XLE, XLF, XLK, SPX, VIX, DJI, LABU Also: IEF, IYT, UDN
Watch
3 Leveraged Healthcare ETFs Soaring This Month
Article By: Benzinga
Tuesday, February 11, 2020 12:50 AM EST
Here are some geared healthcare ETFs that are enjoying fabulous February and may have more in store over the next couple of weeks.
In this article: CURE, LABU, PILL Also: JNJ, PFE, LABD
Read
It's Time To Consider Leveraged Healthcare ETFs
Article By: Benzinga
Friday, June 7, 2019 6:00 PM EST
For traders using leveraged sector exchange-traded funds, one key to successfully using these products in the short-term fashion in which they are intended is to treat leveraged ETFs as event-driven trades.
In this article: CURE, LABU
Read

Latest Tweets for $LABU

No tweets yet!

PARTNER HEADLINES